JOURNAL OF CLINICAL SURGERY ›› 2019, Vol. 27 ›› Issue (4): 331-334.doi: 10.3969/j.issn.1005-6483.2019.04.019

Previous Articles     Next Articles

The expression of STIM1 and osteogenetic differentiation related factors in bone marrow stromal stem cells of postmenopausal osteoporosis patients

  

  1. Department of Orthopedics,Chongqing General Team Hospital of Armed Police Force,Chongqing 400061,China
  • Received:2018-05-30 Online:2019-04-20 Published:2019-04-20

Abstract: Objective To observe the expression of stromal interaction molecule-1(STIM1)and other osteogenetic differentiation related factors (such as ALP,OCN,OPN) in bone marrow stromal stem cells(BMSCs)of postmenopausal osteoporosis patients.Methods BMSCs were cultured in the presence of osteogenic induction for 14d after obtained from postmenopausal osteoporosis patients.We analyzed the Ca2+ concentration and Ca2+ release activated Ca2+channel(CRAC)by Fluo-3 staining before and after osteogenic induction respectively.The expressions of STIM1 and other osteogenic differentiation related factors(ALP,OPN and OCN)were further measured and evaluated by quantitative real time PCR.Mineralization was evaluated by the calcium chelating dye alizarin red at the start of osteogenic induction and after 7 and 14 days.BMSCs were stained for alkaline phosphatase(ALP)at 14d.Results BMSCs were successfully cultured after osteogenic induction for 14d.The expressions of STIM1 and other osteogenic differentiation related factors(ALP,OPN,and OCN)in observation group were lower than the control group by RT-PCR(P<0.05).Similarly,ALP staining was significantly reduced in observation group compared with the normal control cells(P<0.05).Besides,the expression of STIM1 in observation group after osteogenic induction for 14d was reducing,but less than control group.Ca2+ concentration was reduced in observation group than control group(P<0.05).The numbers of calcium chelating dye alizarin red in observation group were less than control group.Conclusion There are significant evidences that STIM1 in BMSCs would be contributed to the postmenopausal osteoporosis,which could provide a new research direction and therapeutic strategy for osteoporosis.

Key words: postmenopausal osteoporosis, bone marrow mesenchymal stem cells, stromal sympathetic molecules 1, alkaline phosphatase, calcium release activated calcium channel

No related articles found!
Viewed
Full text
573
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 0 0 0 573

  From Others local
  Times 83 490
  Rate 14% 86%

Abstract
362
Just accepted Online first Issue
0 0 362
  From Others
  Times 362
  Rate 100%

Cited

Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
[1] . [J]. JOURNAL OF CLINICAL SURGERY, 0, (): 481 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 807 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 865 .
[4] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(12): 896 .
[5] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(12): 916 .
[6] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(12): 931 .
[7] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(6): 413 .
[8] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(6): 437 .
[9] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(8): 635 .
[10] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(8): 592 .